Overview

A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the bioequivalence of Indomethacin ER Capsules.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Indomethacin